Cole, Philip A
- Brigham and Women's Hospital · Internal Medicine (investigator's affiliation)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #12,754
- R01 Holder
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$830.1K
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#12,754
By linked amount among FY2023 PIs
Earliest Year Loaded
2006
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Cole, Philip A as a PI. Multi-PI records show the full award amount for context.
- 1R35GM149229-01R35Contact PIChemical Approaches to Understanding Reversible Lysine ModificationsBrigham and Women's Hospital · Internal Medicine (investigator's affiliation)$447.5Kaward amount
- 5R01CA074305-29R01Contact PIChemical Approaches to Cell Signaling EnzymesBrigham and Women's Hospital · Internal Medicine (investigator's affiliation)$382.6Kaward amount
Award organization
Organizations that administered FY2023 awards listing Cole, Philip A as a PI.
FY2023 award administered by Brigham and Women's Hospital (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2006First NIH AwardBrigham and Women's Hospital
- 2006$500K Cumulative Funding
- 2006Entered Top 50% NationallyRanked #7363
- 2007$1M Cumulative Funding
- 2008$2M Cumulative Funding
- 2012$5M Cumulative Funding
- 2012R01 Grant Holder
- 2019$10M Cumulative Funding
- 2020Entered Top 25% NationallyRanked #3802